Davern Capital sees GLP-1 Opportunities Beyond Obesity
Jun 14 2024
Length: 10 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Please try again

Unfollow podcast failed

Please try again

Davern Capital sees GLP-1 Opportunities Beyond Obesity

Listen for free

View show details

Summary
Davern Capital’s founder, Elie Kobrin, approaches the biopharma market from a long/short perspective – but as a former doctor, he also speaks the language of medicine. He explains the fund’s approach and offers insights on hot topics in the current market.

Show more Show less

Show more Show less

What listeners say about Davern Capital sees GLP-1 Opportunities Beyond Obesity

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon